As of today (2026-06-24), Walpar Nutritions's share price is ₹24.05.
Walpar Nutritions's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5.73. Hence, Walpar Nutritions's Price-to-Operating-Cash-Flow Ratio for today is 4.20.
The historical rank and industry rank for Walpar Nutritions's Price-to-Operating-Cash-Flow or its related term are showing as below:
NSE:WALPAR's Price-to-Operating-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.12 * Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Walpar Nutritions's Cash Flow from Operations per share for the
six
months ended in Mar. 2024 was ₹2.23.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5.73.
Walpar Nutritions Price-to-Operating-Cash-Flow Related Terms
Walpar Nutritions Price-to-Operating-Cash-Flow Historical Data
* Premium members only.
The historical data trend for Walpar Nutritions's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:WALPAR vs ZTS, VTRS: Price-to-Operating-Cash-Flow Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Walpar Nutritions's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Walpar Nutritions Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Walpar Nutritions's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Walpar Nutritions's Price-to-Operating-Cash-Flow falls into.
Walpar Nutritions's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio
=
Share Price
/
Cash Flow from Operations per share (TTM)
=
24.05
/
5.725
=
4.20
Walpar Nutritions's Share Price of today is ₹24.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Walpar Nutritions's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹5.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Price-to-Operating-Cash-Flow of 4.20 mean?
Walpar Nutritions (NSE:WALPAR) has a Price-to-Operating-Cash-Flow of 4.20 as of Jun. 24, 2026. Price-to-operating-cash-flow ratio is the ratio of share price to a company's per-share cash from operations. View historical data on Walpar Nutritions and its competitors.
Is Walpar Nutritions' Price-to-Operating-Cash-Flow too high?
Walpar Nutritions' current Price-to-Operating-Cash-Flow is 4.20. The Drug Manufacturers industry median Price-to-Operating-Cash-Flow is 16.12. Walpar Nutritions' value of 4.20 is 73.9% below this industry median. Overall, Walpar Nutritions has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Walpar Nutritions' Price-to-Operating-Cash-Flow compare to ZTS and VTRS?
Walpar Nutritions' Price-to-Operating-Cash-Flow of 4.20 can be compared against companies in the Drug Manufacturers industry. The industry median Price-to-Operating-Cash-Flow is 16.12. Walpar Nutritions' value of 4.20 is 73.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Operating-Cash-Flow for a Drug Manufacturers company?
The median Price-to-Operating-Cash-Flow among Drug Manufacturers companies is 16.12, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Operating-Cash-Flow significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Operating-Cash-Flow should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Walpar Nutritions's current Price-to-Operating-Cash-Flow of 4.20 is 73.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Operating-Cash-Flow mean?
A high Price-to-Operating-Cash-Flow can signal that a stock is expensive relative to its fundamentals. Price-to-operating-cash-flow ratio is the ratio of share price to a company's per-share cash from operations. View historical data on Walpar Nutritions and its competitors. For the Drug Manufacturers industry, the median Price-to-Operating-Cash-Flow is 16.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Walpar Nutritions's current Price-to-Operating-Cash-Flow is 4.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Walpar Nutritions stock overvalued right now?
Walpar Nutritions (NSE:WALPAR) has a current Price-to-Operating-Cash-Flow of 4.20. The current Price-to-Operating-Cash-Flow is 4.20 and 73.9% below the Drug Manufacturers industry median of 16.12. Walpar Nutritions' overall GF Score™ is 54/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Operating-Cash-Flow calculated?
Price-to-Operating-Cash-Flow is calculated from a company's financial statements. For Walpar Nutritions (NSE:WALPAR), the current Price-to-Operating-Cash-Flow is 4.20 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Walpar Nutritions Ltd is India-based company, which is engaged in manufacturing and trading of pharmaceutical, nutraceutical, herbal and ayurvedic commodities. It also manufactures various private label/third party brands for different companies across the country and overseas, as well as for their own brand sales. It is a manufacturer of various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceutical formulations. It specializes in contract manufacturing, raw materials trading, and direct selling. Its portfolio consists of tablets, capsules, powder/sachets, and oral liquids.
54GF Score
Get the complete analysis for NSE:WALPAR
Price-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:WALPAR has been successfully added to your 
